Biocompatible material comprising poly(e-caprolactone) and a hyaluronic acid derivative for the replacement, repair or regeneration of the meniscus
CA 2591464 C · Owner: Anika Therapeutics S.R.L. · Inventors: Ambrosio, Luigi; Pavesio, Alessandra; Pastorello, Andrea
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Herein described is a biocompatible material comprising a polymer matrix based on hyaluronic acid derivatives and poly-.epsilon.Caprolactone the process for , preparing this material a prosthetic device constituted by this biocompatible material and a reinforcing material, the process for preparing the prosthetic device, and its use for the partial or total replacement of meniscus and , regeneration of the meniscal fibrocartilage.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 14, 2005 and granted October 15, 2013. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended December 14, 2025.
- Certificates of supplementary protection extend only drug patents, and it isn't classified as one.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.